If you've looked up the Wegovy cost per month and felt your stomach drop, you're not alone. Branded semaglutide sits at the top of the GLP-1 price ladder, and figuring out what you'll actually pay — after insurance, discount cards, or a telehealth alternative — takes more than a quick search. This guide breaks down every realistic payment path in 2026, so you can make a decision based on real numbers rather than sticker shock.
Without any coverage or discount program, Wegovy's list price runs above $1,300 per month at the maintenance dose. That number has stayed stubbornly high since Novo Nordisk launched the drug, and it hasn't meaningfully dropped despite growing competition in the GLP-1 space.
Retail price varies slightly by pharmacy and dose. The starting dose (0.25 mg weekly) costs less per pen than the 2.4 mg maintenance dose, so your monthly spend climbs as you titrate up over the first several months. By the time most patients reach maintenance, they're paying the full retail price.
That's the number that sends most people searching for alternatives.
Insurance coverage for Wegovy exists, but it's inconsistent and often comes with real friction. Here's how the main scenarios break down.
Some large employer plans cover Wegovy, particularly those that have added obesity treatment benefits in recent years. When coverage applies, your out-of-pocket cost depends on your plan's tier structure. Wegovy typically lands on a specialty tier, which means higher copays than standard brand drugs.
Patients with solid specialty coverage report paying anywhere from $25 to $200 per month after insurance. But "good coverage" here means a plan that explicitly lists obesity medications as a covered benefit — and many plans still exclude them entirely. The Affordable Care Act doesn't require insurers to cover weight loss drugs, so a significant share of employer plans simply don't.
If you're unsure whether your plan covers Wegovy, call the member services number on your insurance card and ask specifically about "semaglutide for weight management" or "Wegovy." Ask whether prior authorization is required, what the specialty tier copay is, and whether there's a quantity limit or step therapy requirement.
Medicare Part D began covering certain GLP-1 medications for cardiovascular risk reduction after Wegovy received FDA approval for that indication in 2023. Coverage specifically for weight management under Medicare, however, remains limited and varies by plan.
Medicaid coverage differs by state. Some state programs cover Wegovy; others don't. If you're on Medicaid, check your state's preferred drug list directly — it changes more frequently than most people realize.
Novo Nordisk offers a savings card for commercially insured patients. Eligible patients with qualifying insurance can pay as little as $25 per month through this program. The catch: it requires commercial insurance that already covers Wegovy. If your plan doesn't cover it, the savings card typically doesn't apply.
Patients without insurance or with government coverage — Medicare, Medicaid, CHIP — are generally excluded from manufacturer savings programs.
GoodRx and similar discount card programs negotiate lower rates with pharmacy benefit managers. For most generics, GoodRx produces meaningful savings. For brand-name specialty drugs like Wegovy, the picture is more complicated.
GoodRx coupons for Wegovy typically show prices in the $900 to $1,100 range per month, depending on the dose and pharmacy. That's a real discount from retail, but it's still a significant monthly expense for most patients.
A few things worth knowing before using GoodRx for Wegovy:
You can't combine GoodRx with insurance. When you use a coupon, you're paying cash, and the purchase doesn't count toward your deductible or out-of-pocket maximum.
Prices vary by pharmacy. Costco, Mark Cuban's Cost Plus Drugs, and independent pharmacies sometimes show lower GoodRx prices than large chains. It's worth checking multiple locations.
Prices aren't guaranteed. GoodRx rates shift based on negotiated contracts, so what you see today may differ next month.
For most uninsured or underinsured patients, GoodRx reduces the Wegovy cost per month but doesn't bring it into the $150 to $400 range that most cash-pay patients are working with.
The math isn't complicated. Without insurance coverage that brings Wegovy to a manageable copay, you're looking at $900 to $1,300+ per month — or $10,800 to $15,600 per year. That's beyond what most working adults can sustain.
This is why the compounded GLP-1 market grew so quickly. Compounded semaglutide and compounded tirzepatide aren't the same as branded Wegovy or Zepbound, but they use the same active ingredients and are prescribed by licensed providers. The price difference is substantial.
According to Gallup data from August 2026, 11% of Americans are currently taking a GLP-1 medication. A meaningful portion of those patients are accessing medication through telehealth platforms rather than traditional insurance channels — because the branded path is simply out of reach financially.
Telehealth platforms offering compounded GLP-1 medications have filled the gap between "can't afford Wegovy" and "not willing to give up on weight management." The pricing model is different, the medication is different, and the process is different. Here's how it works.
Most telehealth platforms charge a monthly or quarterly subscription that covers the medication, provider consultation, and ongoing follow-up — all bundled together rather than billed separately.
Competitor pricing in this space generally runs from around $149 to $299 per month for compounded semaglutide or tirzepatide, depending on the platform and dose. Ro starts around $149/month, Hims around $199/month, and Henry Meds around $197/month. Found ranges from $199 to $299 for oral medications and higher for injections.
These prices aren't directly comparable to Wegovy because the medications are compounded formulations, not the branded drug. But for patients who need a clinically supervised GLP-1 program at a manageable monthly cost, the telehealth model makes the math work.
The July 2026 JAMA and Yale secret shopper study raised serious concerns about prescribing practices at some telehealth platforms, finding that certain providers weren't conducting adequate medical reviews before prescribing GLP-1 medications. That study changed how patients evaluate these services.
The baseline you should expect from any telehealth GLP-1 provider:
Board-certified provider review. Your intake form should be reviewed by an actual licensed clinician, not just processed by an algorithm. Ask the platform directly who reviews your intake and what credentials they hold.
HIPAA-compliant infrastructure. Your health information must be protected under federal privacy law. This isn't a bonus feature — it's the legal standard.
Ongoing follow-up. GLP-1 therapy involves dose titration, side effect management, and periodic check-ins. A platform that takes your money and goes quiet isn't providing medical care.
Transparent process. You should know exactly what happens between submitting your intake form and receiving your medication.
JoeyMed is a U.S.-based telehealth platform that connects patients with board-certified, licensed U.S. providers through a straightforward three-step process: complete an online health intake form, get reviewed by a provider, and receive a personalized prescription plan shipped discreetly to your home. No insurance required.
JoeyMed offers several GLP-1 plans, including the GLP-1 Core Plan, the GLP-1 Plus Core Plan, and the Tirz HD plan for compounded tirzepatide. All consultations are HIPAA-compliant, shipping is free to all 50 states, and 24/7 customer support is included alongside ongoing provider follow-up.
Specific pricing isn't listed publicly, but the platform runs promotional discounts of up to 50% off. For current plan pricing, visit the JoeyMed weight loss page directly.
Here's a clear summary of what each payment path looks like for a patient managing GLP-1 costs in 2026:
| Payment Path | Typical Monthly Cost | What You Get |
|---|---|---|
| Wegovy, no insurance | $1,300+ | Branded semaglutide, standard pharmacy |
| Wegovy, good insurance coverage | $25–$200 | Branded semaglutide, specialty copay |
| Wegovy, GoodRx | $900–$1,100 | Branded semaglutide, cash discount |
| Novo Nordisk savings card | ~$25 | Requires qualifying commercial insurance |
| Telehealth compounded GLP-1 | ~$149–$299/month (competitors) | Compounded semaglutide or tirzepatide, provider-supervised |
The savings card is the best deal if you qualify. Most people don't. For everyone else, the choice comes down to paying near-retail for branded Wegovy or moving to a telehealth compounded GLP-1 program at a fraction of the cost.
A lot of people searching for Wegovy alternatives end up looking at tirzepatide-based options. Tirzepatide is the active ingredient in Zepbound (weight loss) and Mounjaro (diabetes), and it works on both GLP-1 and GIP receptors — a different mechanism than semaglutide alone.
Compounded tirzepatide is not the same as Zepbound. It's prepared by a compounding pharmacy using tirzepatide as the active ingredient and prescribed through a licensed provider. The FDA has raised concerns about certain compounded GLP-1 products, so the platform and pharmacy you use matters.
JoeyMed's Tirz HD plan is a high-dose tirzepatide formulation available through their platform. As with any compounded medication, your provider reviews your health history before prescribing, and the medication ships directly to your home.
It's worth being direct about something: the U.S. insurance system hasn't kept pace with the clinical evidence on GLP-1 medications for obesity. The American Medical Association classified obesity as a disease in 2013. The FDA approved Wegovy specifically for chronic weight management in 2021. Yet in 2026, millions of patients still can't get coverage for these medications.
KFF data shows roughly 17% of GLP-1 users access medication through online providers. That's not a fringe behavior — it's a significant portion of the patient population finding a way around a coverage system that hasn't caught up to the science.
If you're in that group, you're not doing something unusual. You're navigating a real gap.
If you want to pursue branded Wegovy, here's the sequence to follow:
If you're open to a telehealth compounded GLP-1 program, the process is faster and the cost is more predictable. You fill out a health intake form, a board-certified provider reviews it, and if appropriate, your prescription ships to your door.
What is the average Wegovy cost per month without insurance in 2026? Without insurance or a discount program, Wegovy typically costs over $1,300 per month at the maintenance dose. The starting dose costs less, but the price increases as you titrate up over the first several months of treatment.
Does GoodRx work for Wegovy? GoodRx does offer coupons for Wegovy, but the discounted price typically falls in the $900 to $1,100 range per month, depending on the pharmacy and dose. That's a reduction from retail, but still significant for most cash-pay patients. You can't combine GoodRx with insurance.
How much does Wegovy cost with insurance? It depends heavily on your plan. Patients with employer plans that cover obesity medications and place Wegovy on a specialty tier often pay $25 to $200 per month. Many plans still exclude Wegovy entirely, in which case insurance provides no discount.
Is compounded tirzepatide a legal alternative to Wegovy? Compounded tirzepatide is a different medication from Wegovy, which contains semaglutide. It's prepared by compounding pharmacies and prescribed by licensed providers. The FDA has issued guidance on compounded GLP-1 products, so the platform and pharmacy you use matters. Always ensure your prescription comes from a licensed U.S. provider following a proper medical review.
What do telehealth GLP-1 platforms typically charge per month? Competitor platforms in 2026 charge roughly $149 to $299 per month for compounded semaglutide or tirzepatide programs, with the cost typically covering the medication, provider consultation, and follow-up. Pricing varies by platform and dose tier.
Can I get Wegovy through a telehealth platform? Some telehealth platforms can prescribe branded Wegovy, but most focus on compounded GLP-1 alternatives because the cost difference is significant. If you want branded Wegovy specifically, you'll likely need to go through a traditional pharmacy with insurance or a discount card.
What should I look for in a telehealth GLP-1 provider? Following the July 2026 JAMA and Yale study on telehealth prescribing practices, the key things to verify are: board-certified provider review of your intake, HIPAA-compliant infrastructure, ongoing follow-up and dose management, and transparent communication about what medication you're receiving and from which pharmacy.
The Wegovy cost per month in 2026 is genuinely out of reach for most patients without strong insurance coverage. The savings card helps if you qualify, GoodRx reduces the price modestly, and insurance coverage varies widely. For the large share of patients who fall outside those options, telehealth platforms offering compounded GLP-1 medications provide a clinically supervised path at a fraction of branded pricing.
If you're evaluating that path, the quality of the provider review matters as much as the price. JoeyMed offers board-certified provider review, HIPAA-compliant consultations, free discreet shipping to all 50 states, and 24/7 support — with no insurance required at any step.